Stocks and InvestingStocks and Investing
Wed, February 2, 2022
Tue, February 1, 2022
Mon, January 31, 2022
Sun, January 30, 2022
Fri, January 28, 2022

Mani Foroohar Maintained (ARWR) at Hold with Increased Target to $46 on, Jan 28th, 2022


Published on 2024-10-27 19:29:14 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $45 to $46 on, Jan 28th, 2022.

Mani has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Mani's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mani


  • Madhu Kumar of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Wednesday, January 19th, 2022